MAPT and Alzheimer disease: Given the critical need for advancements in the early detection and differentiation of AD amid its growing global prevalence, this narrative review sets forth to critically evaluate the diagnostic utility of phosphorylated-tau (p-tau) proteins, specifically p-tau Thr217 (p-tau217) and p-tau Thr231 (p-tau231), as potential biomarkers for AD.